List of Tables
Table 1. Uveitis Treatment Drug Market Trends
Table 2. Uveitis Treatment Drug Market Drivers & Opportunity
Table 3. Uveitis Treatment Drug Market Challenges
Table 4. Uveitis Treatment Drug Market Restraints
Table 5. Global Uveitis Treatment Drug Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Uveitis Treatment Drug Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Uveitis Treatment Drug Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Uveitis Treatment Drug Product Type
Table 9. Key Companies Time to Begin Mass Production of Uveitis Treatment Drug
Table 10. Global Uveitis Treatment Drug Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Uveitis Treatment Drug as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Uveitis Treatment Drug Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Uveitis Treatment Drug Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Uveitis Treatment Drug Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Uveitis Treatment Drug Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Uveitis Treatment Drug Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Uveitis Treatment Drug Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Uveitis Treatment Drug Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Uveitis Treatment Drug Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Uveitis Treatment Drug Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Uveitis Treatment Drug Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Uveitis Treatment Drug Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Uveitis Treatment Drug Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Uveitis Treatment Drug Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Uveitis Treatment Drug Sales Value by Region (2019-2024) & (%)
Table 27. Global Uveitis Treatment Drug Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Uveitis Treatment Drug Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Uveitis Treatment Drug Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Uveitis Treatment Drug Sales Value, (2025-2030) & (US$ Million)
Table 31. AbbVie Basic Information List
Table 32. AbbVie Description and Business Overview
Table 33. AbbVie Uveitis Treatment Drug Products, Services and Solutions
Table 34. Revenue (US$ Million) in Uveitis Treatment Drug Business of AbbVie (2019-2024)
Table 35. AbbVie Recent Developments
Table 36. Novartis AG Basic Information List
Table 37. Novartis AG Description and Business Overview
Table 38. Novartis AG Uveitis Treatment Drug Products, Services and Solutions
Table 39. Revenue (US$ Million) in Uveitis Treatment Drug Business of Novartis AG (2019-2024)
Table 40. Novartis AG Recent Developments
Table 41. Bausch Health Companies Inc. Basic Information List
Table 42. Bausch Health Companies Inc. Description and Business Overview
Table 43. Bausch Health Companies Inc. Uveitis Treatment Drug Products, Services and Solutions
Table 44. Revenue (US$ Million) in Uveitis Treatment Drug Business of Bausch Health Companies Inc. (2019-2024)
Table 45. Bausch Health Companies Inc. Recent Developments
Table 46. Galapagos NV Basic Information List
Table 47. Galapagos NV Description and Business Overview
Table 48. Galapagos NV Uveitis Treatment Drug Products, Services and Solutions
Table 49. Revenue (US$ Million) in Uveitis Treatment Drug Business of Galapagos NV (2019-2024)
Table 50. Galapagos NV Recent Developments
Table 51. EyePoint Pharmaceuticals, Inc. Basic Information List
Table 52. EyePoint Pharmaceuticals, Inc. Description and Business Overview
Table 53. EyePoint Pharmaceuticals, Inc. Uveitis Treatment Drug Products, Services and Solutions
Table 54. Revenue (US$ Million) in Uveitis Treatment Drug Business of EyePoint Pharmaceuticals, Inc. (2019-2024)
Table 55. EyePoint Pharmaceuticals, Inc. Recent Developments
Table 56. Clearside Biomedical Basic Information List
Table 57. Clearside Biomedical Description and Business Overview
Table 58. Clearside Biomedical Uveitis Treatment Drug Products, Services and Solutions
Table 59. Revenue (US$ Million) in Uveitis Treatment Drug Business of Clearside Biomedical (2019-2024)
Table 60. Clearside Biomedical Recent Developments
Table 61. Tarsier Pharma Ltd Basic Information List
Table 62. Tarsier Pharma Ltd Description and Business Overview
Table 63. Tarsier Pharma Ltd Uveitis Treatment Drug Products, Services and Solutions
Table 64. Revenue (US$ Million) in Uveitis Treatment Drug Business of Tarsier Pharma Ltd (2019-2024)
Table 65. Tarsier Pharma Ltd Recent Developments
Table 66. Santen Pharmaceutical Co., Ltd. Basic Information List
Table 67. Santen Pharmaceutical Co., Ltd. Description and Business Overview
Table 68. Santen Pharmaceutical Co., Ltd. Uveitis Treatment Drug Products, Services and Solutions
Table 69. Revenue (US$ Million) in Uveitis Treatment Drug Business of Santen Pharmaceutical Co., Ltd. (2019-2024)
Table 70. Santen Pharmaceutical Co., Ltd. Recent Developments
Table 71. Bausch & Lomb Incorporated Basic Information List
Table 72. Bausch & Lomb Incorporated Description and Business Overview
Table 73. Bausch & Lomb Incorporated Uveitis Treatment Drug Products, Services and Solutions
Table 74. Revenue (US$ Million) in Uveitis Treatment Drug Business of Bausch & Lomb Incorporated (2019-2024)
Table 75. Bausch & Lomb Incorporated Recent Developments
Table 76. Sanofi Basic Information List
Table 77. Sanofi Description and Business Overview
Table 78. Sanofi Uveitis Treatment Drug Products, Services and Solutions
Table 79. Revenue (US$ Million) in Uveitis Treatment Drug Business of Sanofi (2019-2024)
Table 80. Sanofi Recent Developments
Table 81. Regeneron Pharmaceuticals, Inc. Basic Information List
Table 82. Regeneron Pharmaceuticals, Inc. Description and Business Overview
Table 83. Regeneron Pharmaceuticals, Inc. Uveitis Treatment Drug Products, Services and Solutions
Table 84. Revenue (US$ Million) in Uveitis Treatment Drug Business of Regeneron Pharmaceuticals, Inc. (2019-2024)
Table 85. Regeneron Pharmaceuticals, Inc. Recent Developments
Table 86. Alimera Sciences Basic Information List
Table 87. Alimera Sciences Description and Business Overview
Table 88. Alimera Sciences Uveitis Treatment Drug Products, Services and Solutions
Table 89. Revenue (US$ Million) in Uveitis Treatment Drug Business of Alimera Sciences (2019-2024)
Table 90. Alimera Sciences Recent Developments
Table 91. Key Raw Materials Lists
Table 92. Raw Materials Key Suppliers Lists
Table 93. Uveitis Treatment Drug Downstream Customers
Table 94. Uveitis Treatment Drug Distributors List
Table 95. Research Programs/Design for This Report
Table 96. Key Data Information from Secondary Sources
Table 97. Key Data Information from Primary Sources
Table 98. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Uveitis Treatment Drug Product Picture
Figure 2. Global Uveitis Treatment Drug Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Uveitis Treatment Drug Sales Value (2019-2030) & (US$ Million)
Figure 4. Uveitis Treatment Drug Report Years Considered
Figure 5. Global Uveitis Treatment Drug Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Uveitis Treatment Drug Revenue in 2023
Figure 7. Uveitis Treatment Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Corticosteroids Picture
Figure 9. Immunosuppressant Picture
Figure 10. Monoclonal Antibodies Picture
Figure 11. Antibiotics Picture
Figure 12. Others Picture
Figure 13. Global Uveitis Treatment Drug Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Uveitis Treatment Drug Sales Value Market Share by Type, 2023 & 2030
Figure 15. Product Picture of Anterior Uveitis
Figure 16. Product Picture of Posterior Uveitis
Figure 17. Product Picture of Intermediate Uveitis
Figure 18. Product Picture of Pan Uveitis
Figure 19. Global Uveitis Treatment Drug Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 20. Global Uveitis Treatment Drug Sales Value Market Share by Application, 2023 & 2030
Figure 21. North America Uveitis Treatment Drug Sales Value (2019-2030) & (US$ Million)
Figure 22. North America Uveitis Treatment Drug Sales Value by Country (%), 2023 VS 2030
Figure 23. Europe Uveitis Treatment Drug Sales Value (2019-2030) & (US$ Million)
Figure 24. Europe Uveitis Treatment Drug Sales Value by Country (%), 2023 VS 2030
Figure 25. Asia Pacific Uveitis Treatment Drug Sales Value (2019-2030) & (US$ Million)
Figure 26. Asia Pacific Uveitis Treatment Drug Sales Value by Country (%), 2023 VS 2030
Figure 27. South America Uveitis Treatment Drug Sales Value (2019-2030) & (US$ Million)
Figure 28. South America Uveitis Treatment Drug Sales Value by Country (%), 2023 VS 2030
Figure 29. Middle East & Africa Uveitis Treatment Drug Sales Value (2019-2030) & (US$ Million)
Figure 30. Middle East & Africa Uveitis Treatment Drug Sales Value by Country (%), 2023 VS 2030
Figure 31. Key Countries/Regions Uveitis Treatment Drug Sales Value (%), (2019-2030)
Figure 32. United States Uveitis Treatment Drug Sales Value, (2019-2030) & (US$ Million)
Figure 33. United States Uveitis Treatment Drug Sales Value by Type (%), 2023 VS 2030
Figure 34. United States Uveitis Treatment Drug Sales Value by Application (%), 2023 VS 2030
Figure 35. Europe Uveitis Treatment Drug Sales Value, (2019-2030) & (US$ Million)
Figure 36. Europe Uveitis Treatment Drug Sales Value by Type (%), 2023 VS 2030
Figure 37. Europe Uveitis Treatment Drug Sales Value by Application (%), 2023 VS 2030
Figure 38. China Uveitis Treatment Drug Sales Value, (2019-2030) & (US$ Million)
Figure 39. China Uveitis Treatment Drug Sales Value by Type (%), 2023 VS 2030
Figure 40. China Uveitis Treatment Drug Sales Value by Application (%), 2023 VS 2030
Figure 41. Japan Uveitis Treatment Drug Sales Value, (2019-2030) & (US$ Million)
Figure 42. Japan Uveitis Treatment Drug Sales Value by Type (%), 2023 VS 2030
Figure 43. Japan Uveitis Treatment Drug Sales Value by Application (%), 2023 VS 2030
Figure 44. South Korea Uveitis Treatment Drug Sales Value, (2019-2030) & (US$ Million)
Figure 45. South Korea Uveitis Treatment Drug Sales Value by Type (%), 2023 VS 2030
Figure 46. South Korea Uveitis Treatment Drug Sales Value by Application (%), 2023 VS 2030
Figure 47. Southeast Asia Uveitis Treatment Drug Sales Value, (2019-2030) & (US$ Million)
Figure 48. Southeast Asia Uveitis Treatment Drug Sales Value by Type (%), 2023 VS 2030
Figure 49. Southeast Asia Uveitis Treatment Drug Sales Value by Application (%), 2023 VS 2030
Figure 50. India Uveitis Treatment Drug Sales Value, (2019-2030) & (US$ Million)
Figure 51. India Uveitis Treatment Drug Sales Value by Type (%), 2023 VS 2030
Figure 52. India Uveitis Treatment Drug Sales Value by Application (%), 2023 VS 2030
Figure 53. Uveitis Treatment Drug Industrial Chain
Figure 54. Uveitis Treatment Drug Manufacturing Cost Structure
Figure 55. Channels of Distribution (Direct Sales, and Distribution)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
